Search research articles
Contact Us
Filters
Showing results (51-60 of 112) with videos related to
Page
of 12
Sort By:
Trends in Immunology
|
June 18, 2003
Immune responsiveness, tolerance and dsRNA: implications for traditional paradigms
Matthias G von Herrath, Adrian Bot
Journal of Translational Medicine
|
January 8, 2013
JTM's Tumor immunology goes broad: announcing the Immunobiology and Immunotherapy section
Adrian Bot, Francesco Marincola, Pedro Romero
Expert Review of Vaccines
|
October 9, 2013
Repositioning therapeutic cancer vaccines in the dawning era of potent immune interventions
Adrian Bot, Francesco Marincola, Kent A Smith
International Reviews of Immunology
|
October 4, 2014
Editorial: international reviews of immunology
Maurizio Chiriva Internati, Leonardo Mirandola, Adrian Bot
Nature Biotechnology
|
January 22, 2026
The dawn of in vivo immune cell engineering in oncology
Adrian Bot, Matthias T Stephan, Saar Gill
Journal of Translational Medicine
|
September 13, 2011
Cancer vaccines at an inflexion point: what next?
Adrian Bot, Mihail Obrocea, Francesco M Marincola
Expert Opinion on Biological Therapy
|
January 9, 2003
Antigen-based immune modulation: DNA vectors and beyond
Adrian Bot, William J Phillips, Matthias von Herrath
DNA and Cell Biology
|
July 3, 2004
Molecular and cellular control of T1/T2 immunity at the interface between antimicrobial defense and immune pathology
Adrian Bot, Kent A Smith, Matthias von Herrath
International Reviews of Immunology
|
January 19, 2012
In this issue: targeting Human Papilloma Virus-associated disease, from cervical to head and neck carcinoma…and more
Maurizio Chiriva-Internati, W Martin Kast, Adrian Bot
Nature Reviews. Drug Discovery
|
November 22, 2025
Accelerating progress in immune cell therapy for solid tumours
Adrian Bot, Mark Dudley, Daniel Shelley, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 112) with videos related to
Sort By:
Page
of 12
Trends in Immunology
|
June 18, 2003
Immune responsiveness, tolerance and dsRNA: implications for traditional paradigms
Matthias G von Herrath, Adrian Bot
Journal of Translational Medicine
|
January 8, 2013
JTM's Tumor immunology goes broad: announcing the Immunobiology and Immunotherapy section
Adrian Bot, Francesco Marincola, Pedro Romero
Expert Review of Vaccines
|
October 9, 2013
Repositioning therapeutic cancer vaccines in the dawning era of potent immune interventions
Adrian Bot, Francesco Marincola, Kent A Smith
International Reviews of Immunology
|
October 4, 2014
Editorial: international reviews of immunology
Maurizio Chiriva Internati, Leonardo Mirandola, Adrian Bot
Nature Biotechnology
|
January 22, 2026
The dawn of in vivo immune cell engineering in oncology
Adrian Bot, Matthias T Stephan, Saar Gill
Journal of Translational Medicine
|
September 13, 2011
Cancer vaccines at an inflexion point: what next?
Adrian Bot, Mihail Obrocea, Francesco M Marincola
Expert Opinion on Biological Therapy
|
January 9, 2003
Antigen-based immune modulation: DNA vectors and beyond
Adrian Bot, William J Phillips, Matthias von Herrath
DNA and Cell Biology
|
July 3, 2004
Molecular and cellular control of T1/T2 immunity at the interface between antimicrobial defense and immune pathology
Adrian Bot, Kent A Smith, Matthias von Herrath
International Reviews of Immunology
|
January 19, 2012
In this issue: targeting Human Papilloma Virus-associated disease, from cervical to head and neck carcinoma…and more
Maurizio Chiriva-Internati, W Martin Kast, Adrian Bot
Nature Reviews. Drug Discovery
|
November 22, 2025
Accelerating progress in immune cell therapy for solid tumours
Adrian Bot, Mark Dudley, Daniel Shelley, et al.
Page
of 12